Combat Cancer, Author at Combat Group

“If patients aren’t fit for or don’t want to have a cystectomy, and prefer bladder preservation, HIVEC is a very good option for them”

by Combat Cancer | Mar 25, 2022 | The Medical Innovators Interview

The Medical Innovators Interview #3 Helena BurdenDecember 2021 Welcome to the third of our new series of interviews with medical innovators – in conversation with Miss Helena Burden, consultant urology surgeon at the Bristol Urological Institute, Southmead Hospital,...

“I think that in ten years we’ll have HIPEC in every single theatre, and with improvements like CO2 agitation it makes even more sense”

by Combat Cancer | Mar 25, 2022 | The Medical Innovators Interview

The Medical Innovators Interview with Associate Professor Ahmad Sayasneh | November 2021 The regular use of HIPEC for ovarian cancer, along with improving pre-surgical diagnostics and visualisation interoperatively, could be a real game-changer. Consultant...

“There’s definitely more work to be done in the BCG-unresponsive field”

by Combat Cancer | Mar 25, 2022 | The Medical Innovators Interview

Welcome to Combat Medical’s first Medical Innovators interview series, where we’ll be exploring ideas and developments in the medical and clinical worlds with the people at the, ahem, cutting edge. To kick off, we’re talking haematuria, urine biomarkers and...

“If patients aren’t fit for or don’t want to have a cystectomy, and prefer bladder preservation, HIVEC is a very good option for them”

“I think that in ten years we’ll have HIPEC in every single theatre, and with improvements like CO2 agitation it makes even more sense”

“There’s definitely more work to be done in the BCG-unresponsive field”

Recent Posts

Recent Comments

Archives

Categories

Meta